Your browser doesn't support javascript.
loading
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies.
Trotman, Judith; Luminari, Stefano; Boussetta, Sami; Versari, Annibale; Dupuis, Jehan; Tychyj, Christelle; Marcheselli, Luigi; Berriolo-Riedinger, Alina; Franceschetto, Antonella; Julian, Anne; Ricard, Fabien; Guerra, Luca; Haioun, Corinne; Biasoli, Irene; Tilly, Hervé; Federico, Massimo; Salles, Gilles; Meignan, Michel.
Afiliación
  • Trotman J; Haematology Department, Concord Hospital, University of Sydney, Sydney, NSW, Australia. Electronic address: judith.trotman@sswahs.nsw.gov.au.
  • Luminari S; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Boussetta S; Department of Biostatistics, The Lymphoma Academic Research Organisation (LYSARC), Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Versari A; Nuclear Medicine Department, Santa Maria Nuova Hospital, IRCCS of Reggio Emilia, Reggio Emilia, Italy.
  • Dupuis J; Unité Hémopathies Lymphoïdes, Hopital Henri Mondor, Creteil, France.
  • Tychyj C; Service de Médecine Nucléaire, Centre Hospitalier Alpes Léman, Contamine sur Arve, France.
  • Marcheselli L; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Berriolo-Riedinger A; Service de Médecine Nucléaire, Centre Georges Francois Leclerc, Dijon, France.
  • Franceschetto A; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Julian A; Service de Médecine Nucléaire, Hôpital Perpan, Toulouse, France.
  • Ricard F; Service de Médecine Nucléaire, Hospices Civils de Lyon, Université Lyon 1, Pierre-Bénite, France.
  • Guerra L; Nuclear Medicine Department, San Gerardo Hospital, University of Milano Bicocca, Monza, Italy.
  • Haioun C; Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor and Université Paris Est Créteil, Créteil, France.
  • Biasoli I; Department of Medicine, University Hospital and School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Tilly H; Département d'Hématologie, UMR918, Centre Henri Becquerel, Université de Rouen, Rouen, France.
  • Federico M; Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Salles G; Service d'Hématologie, Hospices Civils de Lyon, Université Lyon 1, Pierre-Bénite, France.
  • Meignan M; Service de Médecine Nucléaire, Hôpital Henri Mondor and Université Paris Est Créteil, Créteil, France.
Lancet Haematol ; 1(1): e17-27, 2014 Oct.
Article en En | MEDLINE | ID: mdl-27030064

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Haematol Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Haematol Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido